Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-02-17FDA Approved: FLUOROURACIL — Original Application (Sagent Pharmaceuticals)
FDA approves an Original Application for Fluorouracil from Sagent Pharmaceuticals, establishing a generic injectable form of the chemotherap…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment [Phase 2]
This update reports results from a Phase 2 trial evaluating panitumumab regimens in colorectal cancer to estimate the primary treatment resp…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist [NA]
Completed randomized tandem study evaluating G-Eye advanced colonoscopy for improving polyp detection rate across different endoscopists.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating the feasibility of immediate preoperative chemotherapy before resection of colorectal cancer with unrese…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Assessment of Tumor Vascular Effects of Axitinib With Dynamic Ultrasonography in Patients With Metastatic Colorectal Cancer [NA]
This clinical trial update describes Axitinib's effects on tumor vascularity in metastatic colorectal cancer as assessed by dynamic ultrason…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab [Phase 2]
A Phase 2 clinical trial evaluating mechanisms of acquired resistance to panitumumab in metastatic colorectal cancer has completed, with res…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy [Phase 3]
This Phase 3 trial assesses regorafenib versus placebo in Asian patients with metastatic colorectal cancer after standard therapy failure.
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer
An observational study evaluating capecitabine (Xeloda) and oxaliplatin given before and during preoperative pelvic radiotherapy in locally …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial comparing pre-operative CT and PET imaging for metastatic colorectal cancer has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib [Phase 1]
A Phase 1 trial evaluating the combination of capecitabine and oxaliplatin (Xelox) with bevacizumab and dasatinib in patients with solid tum…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Vitamin D Levels in Stage IV Colorectal Cancer Patients [Phase 2]
Phase 2 clinical trial update examining Vitamin D levels in patients with stage IV colorectal cancer; results have been posted.
-
CLINICAL_TRIALS research · 2016-02-03Clinical Trial Update: Novel Endoscopic Imaging Methods for the Evaluation of Blood Vessels in Gastrointestinal Cancers [NA]
This entry reports an update on a clinical trial evaluating novel endoscopic imaging methods to evaluate blood vessels in gastric and colore…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer [Phase 1]
A Phase I trial evaluating the safety, tolerability, anti-tumor activity, and pharmacokinetics of Foxy-5 in metastatic breast cancer, colore…
-
CLINICAL_TRIALS research · 2016-02-02Clinical Trial Update: Pharmacology-driven Dosing of Fluoropyrimidines in Cancer Patients [Phase 4]
A Phase 4 clinical trial exploring pharmacology-driven dosing of fluoropyrimidines in colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Study of IMC-11F8 in Participants With Colorectal Cancer [Phase 2]
A Phase 2 study of IMC-11F8 in participants with metastatic colorectal cancer has completed enrollment and posted results.
-
CLINICAL_TRIALS trial_result · 2016-01-29Clinical Trial Update: Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care [NA]
This update notes the completion of a trial aimed at improving colorectal cancer screening among diverse Hispanic patients in urban primary …
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating panitumumab plus FOLFIRI as first-line treatment for metastatic colorectal cancer. Results posted a…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)
An observational study of capecitabine (Xeloda) in metastatic colorectal cancer (AXIOM) has completed with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: The Value of CE-LUS During Robot-assisted Surgery for Primary Colorectal Cancer [NA]
Completion update on a trial evaluating the value of contrast-enhanced laparoscopic ultrasound (CE-LUS) during robot-assisted surgery for pr…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]
Phase 1 clinical trial evaluating a HER2-positive T cell–mediated adaptive therapy for digestive-system cancers, including esophageal, gastr…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer [Phase 3]
Phase 3 clinical trial evaluating first-line capecitabine (Xeloda) plus bevacizumab in metastatic colorectal cancer; results have been poste…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer [NA]
This clinical trial update summarizes results from a study evaluating combination chemotherapy and bevacizumab with or without radiation the…
-
CLINICAL_TRIALS trial_result · 2016-01-13Clinical Trial Update: Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA [Phase 2]
Phase 2 trial assessing oral methylene blue MMX tablets in colorectal cancer completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Effects of Postoperative Pain Management on Immune Function After Laparoscopic Resection of Colorectal Cancer [NA]
A completed clinical trial update investigating whether postoperative pain management affects immune function after laparoscopic resection o…
-
CLINICAL_TRIALS research · 2016-01-12Clinical Trial Update: Liver MRI for Colorectal Cancer Liver Metastasis: Comparative Effectiveness Research for the Choice of Contrast Agents
Clinical trial update evaluating liver MRI contrast agents for detecting colorectal cancer liver metastases; the study status is currently U…